Calculate NAD+ Dosage Reconstitution Math — Real Peptides

Calculate NAD+ Dosage Reconstitution Math — Real Peptides

Most reconstitution errors don't happen during the mixing step. They occur during dose calculation, when researchers misapply concentration formulas and unknowingly inject 2–3 times the intended amount. The math isn't complex, but the stakes are: a single decimal point error transforms a 50mg dose into 500mg, rendering weeks of experimental work unusable and wasting expensive research compounds.

We've guided hundreds of research teams through peptide protocols across multiple compound classes. The gap between doing reconstitution math correctly and doing it catastrophically wrong comes down to three variables most protocols never explain: total peptide mass, total reconstitution volume, and target dose per injection.

How do you calculate NAD+ dosage reconstitution math accurately?

To calculate NAD+ dosage reconstitution math, divide the total lyophilised peptide mass (mg) by the volume of bacteriostatic water added (mL) to determine concentration. Then divide your target dose (mg) by this concentration to find the injection volume (mL). For a 100mg vial reconstituted with 2mL bacteriostatic water: concentration is 50mg/mL; a 25mg dose requires 0.5mL injection volume.

Yes, you can calculate NAD+ dosage reconstitution math using basic algebra. But most researchers make the same conceptual mistake when converting between concentration and volume. The formula itself is straightforward: Concentration (mg/mL) = Total Peptide Mass (mg) ÷ Reconstitution Volume (mL). What trips people up is the second step. Translating that concentration into the correct syringe draw volume for the desired dose. Research teams often conflate 'dose' with 'volume', leading to errors where they draw based on volume markings without accounting for the actual compound concentration they've created. The rest of this piece covers exactly how concentration math works, how peptide vial labelling affects your calculations, and what preparation mistakes invalidate dosing accuracy entirely.

Understanding NAD+ Peptide Vial Specifications and Labelling

Every lyophilised NAD+ vial arrives with a stated peptide mass. Typically 100mg, 200mg, or 500mg depending on supplier and intended use scale. This number represents the total amount of active NAD+ (nicotinamide adenine dinucleotide) present in the vial as a freeze-dried powder, not the total mass of powder you see, which includes excipients like mannitol or trehalose used to stabilise the peptide structure during lyophilisation. The active peptide mass is what matters for dosage calculation. The filler compounds don't contribute to biological activity and aren't part of the reconstitution math.

When you receive a vial labelled 'NAD 100mg', that 100mg refers exclusively to the NAD+ molecule content as determined by HPLC (high-performance liquid chromatography) analysis during manufacturing. Reputable suppliers like Real Peptides provide certificates of analysis showing purity percentages. A vial labelled 100mg NAD+ at 98% purity contains 98mg of actual NAD+ and 2mg of residual synthesis byproducts or degradation products. For research-grade peptides, purity above 95% is standard; below that threshold, dosing calculations become unreliable because the active compound percentage varies too much batch-to-batch.

The math starts here: before adding any bacteriostatic water, you need to know the exact peptide mass you're working with. If your vial states 100mg and the certificate shows 98% purity, your effective peptide mass is 98mg. Not 100mg. Most researchers skip this adjustment and use the nominal vial mass, which introduces a 2% dosing error from the start. For single-dose experiments, that's negligible; across a 12-week study with daily injections, that 2% compounds into measurable variance in experimental outcomes. Real Peptides' small-batch synthesis with exact amino-acid sequencing ensures batch-to-batch consistency, meaning the purity percentage on your certificate is the number you use for every vial in that lot.

Here's the critical distinction most protocols ignore: total vial mass (the weight of the entire powder) is not the same as active peptide mass (the NAD+ content). A 100mg NAD+ vial might contain 120–150mg of total powder once excipients are included. Weighing the vial contents on a milligram scale and using that number for your concentration calculation is a fundamental error. You'll underestimate concentration by 20–50%, leading to underdosing across your entire study. Always use the labelled peptide mass, adjusted for purity percentage if provided.

The Core Formula: How to Calculate NAD+ Dosage Reconstitution Math Step-by-Step

The relationship between peptide mass, reconstitution volume, and final concentration follows a simple algebraic formula:

Concentration (mg/mL) = Total Peptide Mass (mg) ÷ Reconstitution Volume (mL)

This formula answers the question: how much NAD+ is dissolved in each millilitre of solution after reconstitution? Once you know the concentration, you can calculate the injection volume required for any target dose:

Injection Volume (mL) = Target Dose (mg) ÷ Concentration (mg/mL)

Let's work through a real-world example using a 100mg NAD+ vial. You add 2mL of bacteriostatic water to the vial. Your concentration becomes: 100mg ÷ 2mL = 50mg/mL. This means every 1mL of reconstituted solution contains 50mg of NAD+. If your experimental protocol calls for a 25mg dose per injection, the required injection volume is: 25mg ÷ 50mg/mL = 0.5mL. You would draw 0.5mL (or 50 units on a 1mL insulin syringe marked in 100 units) to deliver exactly 25mg of NAD+.

Now let's adjust the variables. Same 100mg vial, but this time you add 5mL of bacteriostatic water instead of 2mL. Your concentration drops to: 100mg ÷ 5mL = 20mg/mL. To achieve the same 25mg dose, your injection volume becomes: 25mg ÷ 20mg/mL = 1.25mL. You're injecting a larger volume to deliver the same amount of active peptide. The concentration is lower, so more liquid is required to reach the target dose. This is the trade-off: higher reconstitution volumes create lower concentrations, which require larger injection volumes but extend the number of doses you can extract from a single vial.

For subcutaneous injection protocols, injection volume matters beyond just dose accuracy. Volumes above 1.5mL per injection site can cause discomfort, delayed absorption, and depot formation under the skin. If your dose calculation requires injecting 2mL or more to hit your target dose, you've reconstituted at too low a concentration. Either split the dose across two injection sites or start over with a smaller reconstitution volume. Most peptide research protocols target concentrations between 20mg/mL and 100mg/mL specifically to keep injection volumes in the 0.2–1.0mL range, which is the optimal absorption window for subcutaneous administration.

One mistake we see constantly: researchers calculate the dose correctly but draw the wrong volume because they're using a syringe with unfamiliar unit markings. A 1mL insulin syringe is marked in 100 units, where each unit equals 0.01mL. If your calculation says you need 0.3mL, that's 30 units on the syringe. Not 3 units. Mixing up units and millilitres is the single most common dosing error in peptide research, and it's entirely preventable by double-checking syringe graduations before every draw.

Adjusting Reconstitution Volume to Control Concentration and Injection Volume

Reconstitution volume is the variable you control to optimise both concentration and injection volume for your specific protocol. Smaller volumes create higher concentrations, which allow you to deliver larger doses in smaller injection volumes. Larger volumes create lower concentrations, which stretch the number of available doses per vial but require larger injection volumes. The decision isn't arbitrary. It's dictated by your target dose, your injection volume tolerance, and how many doses you need to extract from a single vial.

Let's compare three reconstitution scenarios using the same 100mg NAD+ vial:

Scenario 1: 1mL bacteriostatic water
Concentration = 100mg ÷ 1mL = 100mg/mL. For a 50mg dose: 50mg ÷ 100mg/mL = 0.5mL injection volume. This is a high-concentration solution that delivers large doses in small volumes. Ideal if your protocol requires 50–100mg doses and you want to minimise injection site discomfort.

Scenario 2: 2mL bacteriostatic water
Concentration = 100mg ÷ 2mL = 50mg/mL. For a 50mg dose: 50mg ÷ 50mg/mL = 1.0mL injection volume. This is the middle-ground approach. Moderate concentration, moderate injection volume, commonly used in NAD+ research because 1.0mL is at the upper limit of comfortable subcutaneous injection volume.

Scenario 3: 5mL bacteriostatic water
Concentration = 100mg ÷ 5mL = 20mg/mL. For a 50mg dose: 50mg ÷ 20mg/mL = 2.5mL injection volume. This is a low-concentration solution that requires splitting the dose across multiple injection sites or accepting a larger, slower-absorbing depot injection. The advantage: you can extract more low-dose injections from a single vial. At 10mg per dose, you'd draw 0.5mL per injection and get 10 doses total from the vial.

The calculation here isn't just about concentration. It's about dose flexibility. If your protocol requires dose adjustments over time (e.g., starting at 25mg and titrating up to 100mg), reconstituting at a moderate concentration like 50mg/mL gives you the widest dosing range without requiring impractically small or large injection volumes. Reconstituting at 100mg/mL locks you into high-dose protocols because drawing volumes smaller than 0.1mL (10 units on an insulin syringe) becomes inaccurate with standard syringes.

One practical consideration: once reconstituted, NAD+ peptide solutions are stable for 28 days when refrigerated at 2–8°C in bacteriostatic water. If your protocol calls for daily 10mg injections and you reconstitute a 100mg vial with 2mL water (50mg/mL concentration), you'll draw 0.2mL per dose and exhaust the vial in 10 days. Well within the stability window. But if you're dosing twice weekly, that same vial lasts five weeks, exceeding the 28-day stability limit. In that case, you'd want to reconstitute smaller vials more frequently or accept some potency loss toward the end of the vial's lifespan.

NAD+ Reconstitution: Concentration vs Dose Comparison

The 2mL reconstitution volume (50mg/mL) is the most commonly used concentration for NAD+ research because it balances dose flexibility with practical injection volumes. You can comfortably deliver 25–100mg doses without exceeding 2mL injection volume (the threshold where splitting across sites becomes necessary). Researchers running dose-escalation studies or protocols with variable dosing schedules consistently choose this middle concentration to avoid re-reconstituting vials mid-study.

Key Takeaways

• Calculate NAD+ dosage reconstitution math using the formula: Concentration (mg/mL) = Total Peptide Mass (mg) ÷ Reconstitution Volume (mL), then Injection Volume (mL) = Target Dose (mg) ÷ Concentration (mg/mL).
• A 100mg NAD+ vial reconstituted with 2mL bacteriostatic water creates a 50mg/mL solution. A 25mg dose requires drawing 0.5mL (50 units on a 1mL insulin syringe).
• Smaller reconstitution volumes create higher concentrations, allowing larger doses in smaller injection volumes; larger volumes create lower concentrations, requiring larger draws but stretching the vial across more doses.
• Always use the labelled peptide mass adjusted for purity percentage from the certificate of analysis. Total powder weight includes inactive excipients and will underestimate concentration by 20–50%.
• Reconstituted NAD+ solutions remain stable for 28 days when refrigerated at 2–8°C in bacteriostatic water. Plan reconstitution volumes to exhaust the vial within this stability window.
• Injection volumes above 1.5mL per site cause delayed absorption and discomfort. If your dose calculation requires more than 1.5mL, either split across two sites or reconstitute at a higher concentration.

What If: NAD+ Dosage Reconstitution Scenarios

What If I Need to Reconstitute a 200mg Vial for 50mg Doses?

Add 4mL bacteriostatic water to create a 50mg/mL concentration (200mg ÷ 4mL). Each 50mg dose requires drawing 1.0mL (100 units on a 1mL insulin syringe), giving you four total doses per vial. This concentration keeps injection volumes at the upper comfortable limit for subcutaneous administration while maximising vial efficiency. You won't have leftover solution going to waste, and you'll stay within the 28-day post-reconstitution stability window if dosing twice weekly.

What If My Calculation Requires Drawing Less Than 0.1mL Per Dose?

You've reconstituted at too high a concentration for your target dose. Drawing volumes below 0.1mL (10 units on a standard insulin syringe) introduces unacceptable measurement error. Reconstitute a new vial with a larger bacteriostatic water volume to lower the concentration. For example, if you need 5mg doses from a 100mg vial and initially reconstituted with 1mL (100mg/mL), your draw volume would be 0.05mL. Too small for accuracy. Re-reconstitute with 5mL instead (20mg/mL concentration), and your 5mg dose becomes 0.25mL, which is easily measurable.

What If I Accidentally Added Too Much Bacteriostatic Water?

Your concentration is now lower than intended, which means larger injection volumes to hit target doses. But the math still works. Recalculate concentration using the actual volume you added, not the volume you intended. If you meant to add 2mL to a 100mg vial but accidentally added 3mL, your concentration is 100mg ÷ 3mL = 33.3mg/mL. A 50mg dose now requires 1.5mL instead of 1.0mL. As long as your injection volume stays below 2mL per site, the dosing remains accurate. Just adjust your syringe draw calculations accordingly.

What If I'm Using a Vial With 95% Purity Instead of 98%?

Adjust your effective peptide mass before calculating concentration. A 100mg vial at 95% purity contains 95mg of active NAD+, not 100mg. If you reconstitute with 2mL bacteriostatic water, your concentration is 95mg ÷ 2mL = 47.5mg/mL, not 50mg/mL. A 25mg dose requires 25mg ÷ 47.5mg/mL = 0.526mL instead of 0.5mL. A small difference, but across a multi-week study, ignoring purity adjustment leads to cumulative underdosing that can skew experimental results.

The Unforgiving Truth About NAD+ Reconstitution Errors

Here's the honest answer: if you make a dosing calculation error during reconstitution, there's no way to detect it until you've already administered incorrect doses across days or weeks of your study. NAD+ solutions are colourless and visually identical whether they're 20mg/mL or 100mg/mL. You can't eyeball concentration, and most research labs don't have access to HPLC equipment to verify post-reconstitution potency. The error only becomes apparent when experimental outcomes don't match expected dose-response curves, by which time you've wasted weeks of work and expensive peptide inventory.

The second uncomfortable truth: bacteriostatic water dilution is irreversible. If you add 5mL when you meant to add 2mL, you can't extract the extra liquid without also removing dissolved peptide. Your only option is to recalculate concentration and accept the new injection volumes, or discard the vial and start over. There's no 'undo' in reconstitution math. This is why experienced researchers draw bacteriostatic water into the syringe first, verify the volume twice against the calculation, and only then inject it into the peptide vial. The 15 seconds spent double-checking prevents catastrophic errors that can't be corrected afterward.

The final reality: decimal point errors are catastrophic and invisible. Misplacing a decimal during calculation. Reading 0.5mL as 5.0mL, or calculating 50mg/mL as 5mg/mL. Creates a tenfold dosing error. A single misread decimal means you're injecting ten times the intended dose (destroying dose-response relationships and potentially causing adverse events in biological models) or one-tenth the dose (producing no measurable effect and invalidating the entire study). These errors don't announce themselves. The injection looks normal, the solution behaves normally, and the mistake only surfaces when you analyse results and realise nothing makes sense. We've seen research teams lose months of work to a single transposed decimal during reconstitution.

Reconstitution math is unforgiving because peptides are expensive, stability windows are short, and experimental timelines don't accommodate do-overs. The calculation itself is simple algebra. But the cost of getting it wrong is measured in wasted vials, invalid data, and delayed research milestones. That's why Real Peptides' commitment to quality extends beyond synthesis purity to include clear vial labelling, accessible certificates of analysis, and exact peptide mass specifications. The fewer variables researchers have to estimate or assume during calculation, the lower the error rate across the entire reconstitution process.

The simplest protection against calculation errors: write out every step before you draw a single millilitre. Calculate concentration on paper, double-check the division, calculate injection volume, verify syringe unit markings, then. And only then. Draw bacteriostatic water. The time investment is 90 seconds per reconstitution. The error rate drops to near-zero. Speed is never worth compromising precision when the cost of an error is an entire vial and weeks of experimental work.

If dosing accuracy matters to your research outcomes. And it should. Treat reconstitution math with the same care you'd apply to any other protocol-critical calculation. One careful researcher with a calculator and a written record outperforms ten rushed researchers relying on mental math and muscle memory every time. The math is simple, but the stakes aren't.